- Report
- April 2024
- 75 Pages
Global
From €3500EUR$3,970USD£3,083GBP
- Report
- April 2024
- 75 Pages
Global
From €3500EUR$3,970USD£3,083GBP
- Report
- February 2024
- 71 Pages
Global
From €3500EUR$3,970USD£3,083GBP
- Report
- April 2025
- 50 Pages
Global
From €2503EUR$2,650USD£2,130GBP
Oxiconazole is a topical antifungal drug used to treat dermatological conditions such as tinea pedis, tinea cruris, and tinea corporis. It is available in both cream and lotion forms, and is typically applied twice daily for two to four weeks. Oxiconazole is a broad-spectrum antifungal, meaning it is effective against a wide range of fungi. It is also effective against some bacteria and yeast. Common side effects of oxiconazole include skin irritation, burning, and itching.
Oxiconazole is a relatively new drug, having been approved by the US Food and Drug Administration in 2018. It is marketed by several pharmaceutical companies, including Mylan, Sandoz, and Teva Pharmaceuticals. Other companies involved in the oxiconazole market include Actavis, Dr. Reddy's Laboratories, and Glenmark Pharmaceuticals. Show Less Read more